Curezone Pharma Private Limited
About Curezone Pharma Private Limited
Data last updated:
Curezone Pharma Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290HR2022PTC107861.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Kanta Devi and Nitu Gupta.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.38 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9,596 (net margin -0.3%) and EBITDA of ₹459 (EBITDA margin 0%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Curezone Pharma Private Limited's registered office is in Ambala, Haryana.
- Registered AddressC/O Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curezone Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curezone Pharma Private Limited, buy the company report.
Financials of Curezone Pharma Private Limited
FY 2025 filings availableCurezone Pharma Private Limited reported revenue of ₹33.38 Lakh (up 183% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 183% in the latest year. EBITDA rose 102% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹459 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹9,596 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0% | ||
| Net Profit Margin | -0.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Curezone Pharma Private Limited, buy the company report.
Board of directors of Curezone Pharma Private Limited
Curezone Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanta Devi | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
| Nitu Gupta | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Curezone Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sonix Commercials Pvt Ltd | ₹33.39 Lakh (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Kalmont Technologies Pvt Ltd | ₹33.39 Lakh (FY 2023) | -29.0% | Kolkata, West Bengal, India | |||
| Aggarwal Agencies Private Limited | ₹33.38 Lakh (FY 2025) | -50.0% | Jammu, Jammu and Kashmir, India | |||
| Excel Scales Pvt.Ltd. | ₹33.38 Lakh (FY 2025) | 6.0% | Telangana, India | |||
| Auxinic Health Care Private Limited | ₹33.38 Lakh (FY 2019) | -18.0% | Tisgaon, Maharashtra, India | |||
| Curezone Pharma Private Limitedthis company | ₹33.38 Lakh (FY 2025) | -₹9,596 | -0.3% | 183.0% | Ambala, Haryana, India | |
| Bellis Biotech Private Limited | ₹33.37 Lakh (FY 2016) | -19.0% | Bengaluru, Karnataka, India | |||
| Klasmek Solutions Private Limited | ₹33.37 Lakh (FY 2024) | 22.0% | Nagpur, Maharashtra, India | |||
| Digitalservo Grid Power Private Limited | ₹33.36 Lakh (FY 2022) | 822.0% | Delhi, India | |||
| Tricon Spinners Pvt Ltd | ₹33.36 Lakh (FY 2019) | -13.0% | Amritsar, Punjab, India | |||
| Vepocera India Private Limited | ₹33.36 Lakh (FY 2021) | -62.0% | Delhi, India |
To see the full peer comparison of Curezone Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curezone Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curezone Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Curezone Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curezone Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Kanta Devi was appointed as Director on 21 Nov 2022.
Frequently asked questions
Curezone Pharma is an active private limited company based in Ambala, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 November 2022 (4+ years old) and is registered under CIN U24290HR2022PTC107861.
Curezone Pharma has 2 current directors:
- Kanta Devi - Director
- Nitu Gupta - Director
The latest financial statements of Curezone Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Curezone Pharma is U24290HR2022PTC107861. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curezone Pharma was incorporated on 21 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Curezone Pharma by revenue are Sonix Commercials Pvt Ltd, Kalmont Technologies Pvt Ltd, Aggarwal Agencies Private Limited, Excel Scales Pvt.Ltd, Auxinic Health Care Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kanta Devi was appointed as Director on 21 Nov 2022. Nitu Gupta was appointed as Director on 21 Nov 2022.
The registered office of Curezone Pharma is at CO Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004.
Curezone Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Curezone Pharma is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Curezone Pharma can be reached at its registered office: CO Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004.